Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes

Published:2008-08 Issue:3 Volume:142 Page:379-393
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Gabrilove Janice,Paquette Ronald,Lyons Roger M.,Mushtaq Chaudhry,Sekeres Mikkael A.,Tomita Dianne,Dreiling Lyndah

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07181.x/fullpdf

Reference50 articles.

1. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology;Alessandrino;Haematologica,2002

2. Biological significance of proliferation, apoptosis, cytokines, and monocytemacrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome;Allampallam;International Journal of Hematology,2002

3. Transfusion independence in patients with myelodysplastic syndromes: impact on outcomes and quality of life;Balducci;Cancer,2006

4. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study;Balleari;Annals of Hematology,2006

5. Proposals for the classification of the myelodysplastic syndromes;Bennett;British Journal of Haematology,1982

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome;Current Treatment Options in Oncology;2024-05-30

2. Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities;Current Hematologic Malignancy Reports;2024-04-18

3. Next-generation therapy for lower-risk MDS;Hematology;2023-12-08

4. Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review;Blood Reviews;2023-09

5. Raising the bar for lower-risk myelodysplastic syndromes;Leukemia & Lymphoma;2023-04-08